Literature DB >> 20364878

Differential effects on effort discounting induced by inactivations of the nucleus accumbens core or shell.

Sarvin Ghods-Sharifi1, Stan B Floresco.   

Abstract

The authors investigated the contribution of the nucleus accumbens (NAc) core and shell to effort-based decision making using a discounting procedure. Selection of 1 lever delivered a smaller, 2-pellet reward immediately, whereas the other lever delivered a 4-pellet reward after a fixed ratio of presses (2, 5, 10, or 20) that increased over 4 blocks of 10 discrete choice trials. Subsequent testing employed an equivalent delays procedure, whereby the relative delay to reward delivery after selection of either option was equalized. In well-trained rats, inactivation of the core, but not the shell, via infusion of GABA A/B agonists muscimol/baclofen reduced preference for the high-effort option under standard conditions and also when rats were tested using an equivalent delays procedure. However, inactivation of the core did not alter preference for 4-pellet versus 2-pellet rewards when the relative costs of each option were the same (1 press). Thus, the NAc core, but not the shell, appears to be part of a neural circuit that biases choice toward larger rewards associated with a greater effort cost. Furthermore, the contributions by the NAc core to this form of decision making can be dissociated from its role in delay discounting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364878     DOI: 10.1037/a0018932

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  65 in total

Review 1.  Dopamine in motivational control: rewarding, aversive, and alerting.

Authors:  Ethan S Bromberg-Martin; Masayuki Matsumoto; Okihide Hikosaka
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

Review 2.  Neurophysiology of Reward-Guided Behavior: Correlates Related to Predictions, Value, Motivation, Errors, Attention, and Action.

Authors:  Gregory B Bissonette; Matthew R Roesch
Journal:  Curr Top Behav Neurosci       Date:  2016

3.  Acute stress induces selective alterations in cost/benefit decision-making.

Authors:  Naghmeh Shafiei; Megan Gray; Victor Viau; Stan B Floresco
Journal:  Neuropsychopharmacology       Date:  2012-05-09       Impact factor: 7.853

4.  Anabolic-androgenic steroids and decision making: Probability and effort discounting in male rats.

Authors:  Kathryn G Wallin; Jasmin M Alves; Ruth I Wood
Journal:  Psychoneuroendocrinology       Date:  2015-04-04       Impact factor: 4.905

5.  Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens.

Authors:  Bettina Mai; Susanne Sommer; Wolfgang Hauber
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

6.  Contributions of the nucleus accumbens and its subregions to different aspects of risk-based decision making.

Authors:  Colin M Stopper; Stan B Floresco
Journal:  Cogn Affect Behav Neurosci       Date:  2011-03       Impact factor: 3.282

7.  Neurons in the nucleus accumbens promote selection bias for nearer objects.

Authors:  Sara E Morrison; Saleem M Nicola
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

8.  Limbic-motor integration by neural excitations and inhibitions in the nucleus accumbens.

Authors:  Sara E Morrison; Vincent B McGinty; Johann du Hoffmann; Saleem M Nicola
Journal:  J Neurophysiol       Date:  2017-08-09       Impact factor: 2.714

9.  Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost.

Authors:  Ina Filla; Matthew R Bailey; Elke Schipani; Vanessa Winiger; Chris Mezias; Peter D Balsam; Eleanor H Simpson
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

10.  Anabolic-androgenic steroids and cognitive effort discounting in male rats.

Authors:  Lisa B Dokovna; Grace Li; Ruth I Wood
Journal:  Horm Behav       Date:  2019-05-08       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.